Core Unit Biomarker "Immunocheck"

Development of biomarkers for preclinical and clinical immunomonitoring.

You are here:

Core Unit Biomarker "Immunocheck"

The Core Unit Biomarker "Immunocheck" deals with the development and validation of and research into biomarkers to accompany new treatment approaches in third party funded, investigator-initiated trials. Another main goal is the development of stratification parameters for the personalization of immunological and regenerative therapies (precision medicine).

To ensure the high regulatory standards of an accredited laboratory for the analysis of biological test subjects / patient samples from clinical proof-of-concept trials whilst ensuring the necessary flexibility in the development of new tests and exploratory clinical trials, the core unit is divided into two subunits that are closely linked (see organizational chart).

For more information, please switch to the German version!

Organization Chart

Please click to enlarge!